Susquehanna raised the firm’s price target on MaxLinear (MXL) to $18 from $15 and keeps a Neutral rating on the shares. The firm updated its model following solid Q2 results and even stronger guidance as the company benefits from strength across its strategic growth markets (notably high-speed optical interconnects), as well as a continued recovery in the core business.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MXL:
- MaxLinear price target raised to $18 from $11 at Roth Capital
- Positive Outlook for Maxlinear: Buy Rating Supported by Strong Recovery and Growth Prospects
- MaxLinear price target raised to $18 from $13 at Wells Fargo
- MaxLinear Reports Strong Q2 2025 Financial Results
- MaxLinear reports Q2 EPS 2c, consensus 2c